AAPG
AAPG
Positions held
Your positionsAAPG isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | — | Enterprise value | — | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | — | Beta | — | Dividend yield | — |
| Revenue growth | — | Earnings growth | — | Gross margin | — | Operating margin | — |
| Profit margin | — | ROE | — | ROA | — | Debt / equity | — |
| Current ratio | — | Free cash flow | — | Analyst recommendation | — | Mean target | — |
| 52w high | — | 52w low | — |
Quarterly
No data yet.
Yearly (6y)
No data yet.
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-05 · 3 Small-Cap Stocks With Catalysts That Could Put Them in the Spotlight
2026-09-02 · Ascentage Pharma to Participate in Four Upcoming Investor Conferences
2026-08-28 · Ascentage Pharma Group International (SEHK:6855) Could Be 18% Undervalued After Half Year Losses
2026-08-21 · ASCENTAGE PHARMA GROUP INTERNATIONAL Q2 2026 Earnings Call Summary
2026-08-20 · Ascentage Pharma Group International H1 Earnings Call Highlights
2026-08-20 · Ascentage Pharma H1 Loss Widens, Revenue Rises
2026-08-19 · Ascentage Pharma Reports 2026 Interim Unaudited Financial Results and Provides Business Updates
2026-08-13 · Ascentage Pharma to Participate in the Evercore 2nd Annual China Biotech Summit
2026-08-05 · CORRECTION: Ascentage Pharma to Report 2026 Six Month Interim Results and Provide Corporate Update on August 19, 2026
2026-08-05 · Ascentage Pharma to Report 2026 Six Month Interim Results and Provide Corporate Update on August 19, 2026
2026-08-02 · Ascentage Pharma Appoints Dr. Faiçal Miyara as Chief Business Officer and Jim Ziegler as Chief Commercial Officer
Price (daily)
Full chart · RSI · MACD · patterns